MedTrace Logo

Clinical Prognostic Score to Predict Relapse in VL

NCT05602610 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 741

Last updated 2024-03-05

No results posted yet for this study

Summary

This prospective cohort study has the aim to develop a prognostic tool to predict relapse in patients suffering from visceral leishmaniasis (VL) from VL endemic regions in Ethiopia.

Therefore, comprehensive clinical and laboratory characterization of all confirmed VL patients before and during treatment will be performed in order to identify the factors that determine prognosis of the patients. This approach would result in more efficient patient care and would reduce the case fatality and morbidity, and improve follow-up and care for those at risk of VL relapse.

Conditions

  • Visceral Leishmaniasis

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • University of Gondar

    collaborator OTHER

  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Saskia van Henten, MD · Institute of Tropical Medicine Antwerp, Antwerp, Belgium

  • Eleni Ayele, MD · University of Gondar, Gondar, Ethiopia

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-03
Primary Completion
2026-12-31
Completion
2027-06-30

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05602610 on ClinicalTrials.gov